Rocket Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
RCKT chart
What traders are saying about $RCKT
Latest postsRocket Pharmaceuticals, Inc. news
- Rocket Pharmaceuticals, Inc. Estimates – HAN:9IP1
TradingView ·
- A Quick Look at Today's Ratings for Rocket Pharmaceuticals(RCKT.US), With a Forecast Between $5 to $15
Moomoo ·
- Rocket Pharmaceuticals to Participate in Chardan’s 10th Annual Healthcare Conference
Yahoo Finance ·
- Rocket Pharmaceuticals shares rise 4% after securing access to $150 million credit facility
proactiveinvestors.com ·
- Rocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar
Yahoo Finance ·
- MARKETS LIVE: Wall Street ends lower as 30-year Treasury yield hits 2002 high
proactiveinvestors.com ·
- Rocket receives $150m credit facility to advance cardiovascular portfolio
pharmaceutical-technology.com ·
- Rocket Pharmaceuticals Details RP-A501 Pivotal Plan After Safety Reset
marketbeat.com ·
- Rocket Pharmaceuticals Secures Strategic Credit Facility for Up to $150 Million from Hercules Capital
Yahoo Finance ·
- Rocket Pharmaceuticals (RCKT) Gets FDA Alignment on Heart Drug Trial. Can it Ease Safety Concerns?
Yahoo Finance ·
- Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
biopharmadive.com ·
- RCKT Aligns With FDA on Completing Phase II Study in Danon Disease
Yahoo Finance ·
Rocket Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net income | -$223.1M | -$258.7M | -$245.6M | -$221.9M |
| Diluted EPS | $-2.01 | $-2.73 | $-2.92 | $-3.26 |
| Total assets (year end) | $330.4M | $527.7M | $566.3M | $551.8M |
| Cash and equivalents (year end) | $77.6M | $163.6M | $55.9M | $140.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Rocket Pharmaceuticals, Inc.
- Ticker
- RCKT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1281895
- Former names
- INOTEK PHARMACEUTICALS CORP
Frequently asked questions
What exchange is Rocket Pharmaceuticals, Inc. listed on?
Rocket Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol RCKT.
What industry is Rocket Pharmaceuticals, Inc. in?
Rocket Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Rocket Pharmaceuticals, Inc. headquartered?
Rocket Pharmaceuticals, Inc.'s business address on file with the SEC is in New York, NY.
When does Rocket Pharmaceuticals, Inc.'s fiscal year end?
Rocket Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Rocket Pharmaceuticals, Inc. report?
Rocket Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.